187 related articles for article (PubMed ID: 19630914)
1. Antibodies against a class II HLA-peptide complex raised by active immunization of mice with antigen mimicking peptides.
Dam-Tuxen R; Riise E
Scand J Immunol; 2009 Aug; 70(2):93-100. PubMed ID: 19630914
[TBL] [Abstract][Full Text] [Related]
2. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
Li Y; Li H; Martin R; Mariuzza RA
J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals.
Jaraquemada D; Martin R; Rosen-Bronson S; Flerlage M; McFarland HF; Long EO
J Immunol; 1990 Nov; 145(9):2880-5. PubMed ID: 1698864
[TBL] [Abstract][Full Text] [Related]
5. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
[TBL] [Abstract][Full Text] [Related]
6. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
Rich C; Link JM; Zamora A; Jacobsen H; Meza-Romero R; Offner H; Jones R; Burrows GG; Fugger L; Vandenbark AA
Eur J Immunol; 2004 May; 34(5):1251-61. PubMed ID: 15114658
[TBL] [Abstract][Full Text] [Related]
7. The HLA-DP2 protein binds the immunodominant epitope from myelin basic protein, MBP85-99, with high affinity.
Hansen BE; Nielsen CH; Madsen HO; Ryder LP; Jakobsen BK; Svejgaard A
Tissue Antigens; 2011 Mar; 77(3):229-34. PubMed ID: 21299528
[TBL] [Abstract][Full Text] [Related]
8. A functional and structural basis for TCR cross-reactivity in multiple sclerosis.
Lang HL; Jacobsen H; Ikemizu S; Andersson C; Harlos K; Madsen L; Hjorth P; Sondergaard L; Svejgaard A; Wucherpfennig K; Stuart DI; Bell JI; Jones EY; Fugger L
Nat Immunol; 2002 Oct; 3(10):940-3. PubMed ID: 12244309
[TBL] [Abstract][Full Text] [Related]
9. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
[TBL] [Abstract][Full Text] [Related]
10. HLA, molecular mimicry and multiple sclerosis.
Liblau R; Gautam AM
Rev Immunogenet; 2000; 2(1):95-104. PubMed ID: 11324698
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of molecular mimicry.
Wucherpfennig KW
J Autoimmun; 2001 May; 16(3):293-302. PubMed ID: 11334495
[TBL] [Abstract][Full Text] [Related]
12. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
Markovic-Plese S
Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis.
Tejada-Simon MV; Zang YC; Hong J; Rivera VM; Zhang JZ
Ann Neurol; 2003 Feb; 53(2):189-97. PubMed ID: 12557285
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics at the receptor level of immunodominant myelin basic protein epitope 87-99 implicated in multiple sclerosis and its antagonists altered peptide ligands: triggering of immune response.
Mantzourani ED; Platts JA; Brancale A; Mavromoustakos TM; Tselios TV
J Mol Graph Model; 2007 Sep; 26(2):471-81. PubMed ID: 17392002
[TBL] [Abstract][Full Text] [Related]
15. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein.
Mao YS; Lu CZ; Wang X; Xiao BG
Exp Neurol; 2007 Aug; 206(2):231-9. PubMed ID: 17617406
[TBL] [Abstract][Full Text] [Related]
16. Multiple epitopes in a dodecapeptide of myelin basic protein determined by monoclonal antibodies.
Price JO; Whitaker JN; Vasu RI; Metzger DW
J Immunol; 1986 Apr; 136(7):2426-31. PubMed ID: 2419434
[TBL] [Abstract][Full Text] [Related]
17. Peptide binding inhibits aggregation of soluble MHC class II in solution.
Arimilli S; Astafieva I; Mukku PV; Cardoso C; Deshpande S; Nag B
IUBMB Life; 1999 Nov; 48(5):483-91. PubMed ID: 10637763
[TBL] [Abstract][Full Text] [Related]
18. Autocatalytic cleavage of myelin basic protein: an alternative to molecular mimicry.
D'Souza CA; Wood DD; She YM; Moscarello MA
Biochemistry; 2005 Sep; 44(38):12905-13. PubMed ID: 16171406
[TBL] [Abstract][Full Text] [Related]
19. Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor.
Greene MT; Ercolini AM; DeGutes M; Miller SD
J Autoimmun; 2008 Dec; 31(4):399-407. PubMed ID: 19008075
[TBL] [Abstract][Full Text] [Related]
20. HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis.
Ramasamy R; Mohammed F; Meier UC
Immunol Lett; 2020 Jan; 217():15-24. PubMed ID: 31689443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
